Comparison of PPV and LVOT VTI During Passive Leg Raising to Predict Fluid Responsiveness

December 13, 2025 updated by: Ahmet Salih Tüzen, MD, Izmir Katip Celebi University

Comparison of Pulse Pressure Variation and LVOT VTI-Based Cardiac Output Changes During Passive Leg Raising Maneuver in Predicting Fluid Responsiveness in Mechanically Ventilated Critically Ill Patients: A Prospective Observational Study

Hemodynamic instability remains one of the leading causes of morbidity and mortality among critically ill patients in intensive care units. One major contributor to this instability is intravascular fluid deficit. Although fluid administration is often preferred as an initial intervention, inaccurate estimation of fluid requirements carries significant risks. Inadequate resuscitation may lead to tissue hypoperfusion and organ dysfunction, whereas excessive fluid loading is associated with pulmonary edema, increased intra-abdominal pressure, multi-organ dysfunction, and increased mortality. Consequently, reliable prediction of fluid responsiveness is considered a critical determinant in modern intensive care management.

The limited reliability of static parameters in predicting fluid responsiveness and the fact that PPV retains its validity only under specific clinical conditions highlight the need for more effective methods. In recent years, hemodynamic changes assessed during the passive leg raising (PLR) maneuver have gained prominence; particularly, left ventricular outflow tract velocity time integral (LVOT VTI)-based cardiac output measurements have been identified as a strong parameter for predicting fluid responsiveness . Moreover, changes in pulse pressure variation (PPV) during PLR have also been reported as a potential predictor; however, the number of studies prospectively comparing PPV variation and LVOT VTI-based cardiac output change within the same patient population remains limited . Therefore, the proposed study aims to fill this gap in the literature and contribute to fluid management in the intensive care setting.

The aim of this study is to compare the performance of PPV variation and LVOT VTI-based cardiac output change after the PLR maneuver in predicting fluid responsiveness among mechanically ventilated critically ill patients, and to determine the diagnostic value of both methods. The findings of the present study are expected to support more reliable decision-making in fluid therapy and provide clinical evidence toward the individualization of fluid management in intensive care practice.

Study Overview

Detailed Description

This study is designed as a prospective observational trial. No additional intervention, procedure, or treatment beyond standard clinical practice will be performed. All data will be obtained during routine clinical management in our intensive care unit.

In mechanically ventilated patients with suspected fluid deficit, the passive leg raising (PLR) maneuver is applied as part of standard practice, during which changes in pulse pressure variation (PPV) are recorded by invasive arterial monitoring.

In this observational study, transthoracic echocardiographic (TTE) measurements of LVOT VTI will be performed by an experienced operator in addition to routine practice. Using pulse wave Doppler (PW), LVOT VTI will be recorded, and stroke volume (SV) and cardiac output (CO) will be calculated by multiplying the LVOT VTI value by the LVOT diameter. Consequently, changes in PPV and LVOT VTI-based CO during PLR will be compared.

Following TTE measurements of LVOT VTI and LVOT diameter in both the semi-recumbent position (45°) and immediately after PLR, SV and CO will be calculated. Based on these measurements, patients will be allocated into two groups:

  • Fluid responsive: Patients showing ≥10% increase in LVOT VTI-based CO following PLR
  • Non-fluid responsive: Patients showing <10% change in LVOT VTI-based CO following PLR

After grouping patients accordingly, PPV changes during PLR will be compared between the two groups. This will allow evaluation of the predictive performance of PPV variation relative to LVOT VTI-based CO change in determining fluid responsiveness. All measurements will be performed by an experienced clinician without disrupting standard patient care. No additional fluid loading, invasive procedures, or therapeutic interventions will be undertaken throughout the study.

The primary aim is to compare the diagnostic performance of PPV variation and LVOT VTI-based cardiac output changes following a PLR maneuver in predicting fluid responsiveness. The study seeks to determine the diagnostic value of both methods to support more individualised fluid management.

The recorded data will include:

  • Pre- and post-PLR LVOT VTI, stroke volume, cardiac output, and PPV values
  • Routine monitoring parameters (systolic/diastolic blood pressure, mean arterial pressure, heart rate, and SpO₂)
  • Demographic characteristics (age, sex, comorbidities) retrieved through the hospital database

Informed consent will be obtained from all participating patients or their legally authorized representatives.

Study Type

Observational

Enrollment (Estimated)

48

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Ahmet Salih Tüzen, M.D.
  • Phone Number: +90 535 391 55 77
  • Email: astuzen@icloud.com

Study Contact Backup

Study Locations

      • Izmir, Turkey (Türkiye)
        • Izmir Katip Celebi University Atatürk Training and Research Hospital İzmir, , Turkey
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

The study population consists of adult critically ill patients admitted to the Intensive Care Unit (ICU) who are receiving mechanical ventilation support. Eligible participants are those identified by the intensive care team as having a suspected intravascular fluid deficit, for whom a fluid responsiveness assessment is clinically indicated. The cohort specifically targets patients undergoing the Passive Leg Raising (PLR) maneuver as part of routine standard practice, where invasive arterial monitoring is available to record Pulse Pressure Variation (PPV).

Description

Inclusion Criteria:

  1. Adult patients aged ≥18 years
  2. Patients admitted to the intensive care unit receiving mechanical ventilation
  3. Presence of suspected intravascular fluid deficit (hypotension, negative fluid balance, or clinical signs of peripheral hypoperfusion)
  4. Patients in sinus rhythm
  5. Presence of invasive arterial blood pressure monitoring
  6. Adequate echocardiographic window allowing transthoracic echocardiographic measurement of LVOT VTI
  7. Patients ventilated with tidal volume ≥8 mL/kg (ideal body weight)
  8. Hemodynamically stable enough to allow measurement

Exclusion Criteria:

  1. Patients under 18 years of age
  2. Presence of atrial fibrillation or significant arrhythmias such as frequent ventricular or atrial ectopy
  3. Severe right ventricular dysfunction or significant tricuspid regurgitation
  4. Advanced aortic valve disease (severe stenosis or severe regurgitation)
  5. Patients with significant spontaneous breathing effort
  6. Patients receiving lung-protective low tidal volume ventilation strategy (<8 mL/kg) due to ARDS
  7. Inadequate echocardiographic window for LVOT VTI assessment
  8. Severe hemodynamic instability during measurement (sudden vasopressor escalation or need for resuscitation)
  9. Patients who refuse to participate or from whom written informed consent cannot be obtained from themselves or a first-degree relative

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Fluid Responders
Defined as an increase in LVOT VTI-based Cardiac Output (CO) of ≥ 10% from baseline.
Fluid Non-Responders
Defined as an increase in LVOT VTI-based Cardiac Output (CO) of < 10% from baseline.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Pulse Pressure Variation (Delta PPV)
Time Frame: Baseline (T0) and between 60 seconds after the PLR maneuver.
Pulse Pressure Variation (PPV) is recorded via invasive arterial monitoring at baseline (T0, semi-sitting) and during the Passive Leg Raising maneuver (T1).
Baseline (T0) and between 60 seconds after the PLR maneuver.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Percentage Change in Cardiac Output (Delta CO)
Time Frame: Baseline (T0) and between 60 seconds after the PLR maneuver.
Cardiac Output (CO) is calculated using the Left Ventricular Outflow Tract Velocity Time Integral (LVOT VTI) and the LVOT diameter measured via transthoracic echocardiography.
Baseline (T0) and between 60 seconds after the PLR maneuver.
Correlation between Delta PPV and Delta CO
Time Frame: Baseline (T0) and between 60 seconds after the PLR maneuver.
Correlation Coefficient (r) between PPV Change and Cardiac Output Change
Baseline (T0) and between 60 seconds after the PLR maneuver.
Hemodynamic Parameter Changes (MAP, HR)
Time Frame: Baseline (T0) and between 60 seconds after the PLR maneuver.
Measurement of changes in mean arterial pressure and heart rate before and after PLR and comparison between groups.
Baseline (T0) and between 60 seconds after the PLR maneuver.
Diagnostic Accuracy (ROC-AUC, Sensitivity, Specificity, Cut-off)
Time Frame: Baseline (T0) and between 60 seconds after the PLR maneuver.
Evaluation of diagnostic performance of ΔPPV and ΔCO using receiver operating characteristic (ROC) analysis, including AUC, optimal cut-off value, sensitivity, and specificity for predicting fluid responsiveness.
Baseline (T0) and between 60 seconds after the PLR maneuver.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Murat Aksun, Izmir Katip Celebi University Ataturk Training and Research Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

January 1, 2026

Primary Completion (Estimated)

January 1, 2027

Study Completion (Estimated)

June 1, 2027

Study Registration Dates

First Submitted

December 13, 2025

First Submitted That Met QC Criteria

December 13, 2025

First Posted (Actual)

December 26, 2025

Study Record Updates

Last Update Posted (Actual)

December 26, 2025

Last Update Submitted That Met QC Criteria

December 13, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

All data necessary to support the study protocol, including de-identified individual participant data (IPD) related to study protocol, and primary and secondary outcome measures, will be made available upon reasonable request from qualified researchers for academic purposes, in accordance with institutional and ethical guidelines.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Critical Illness

Subscribe